POLISH FINANCIAL SUPERVISION AUTHORITY
UNI - EN REPORT No7/2020
Date of issue:2020-03-19
Short name of the issuer
SOPHARMA AD
Subject
Annual Audited Individual Financial Statements for 2019 of Sopharma AD
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:
Annual Audited Individual Financial Statements for 2019 of Sopharma AD: Individual Audited Financial Report according to IFRS as at 31 December 2019 Notes to the Individual Audited financial report as at 31 December 2019 Management report as at 31 December 2019 Individual Audited Financial Report according to BFSC standards as at 31 December 2019 Auditor's declaration as at 31 December 2019 Auditor's report as at 31 December 2019 Corporate Governance Declaration as at 31 December 2019 Report regarding the application of the remuneration policy as at 31 December 2019 Declaration by responsible directors as at 31 December 2019 Non-financial Declaration to the Annual Financial Report as at 31 December 2019 Individual Audited Financial Report according to IFRS as at 31 December 2019 - xls
Annexes
FileDescription
3JR_Annual_Audited_Individual_Financial_Statements_ for_ 2019.zipAnnual Audited Individual Financial Statements for 2019 of Sopharma AD
SOPHARMA AD
(fullname of the issuer)
SOPHARMA ADFarmaceutyczny (far)
(short name of the issuer)(sector according to clasification of the WSE in Warsow)
1220Sofia
(post code)(city)
IlienskoShosse16
(street)(number)
+359 2 813 42 00+359 2 936 02 86
(phone number)(fax)
(e-mail)(web site)
nd
(NIP)(REGON)
SIGNATURE OF PERSONS REPRESENTING THE COMPANY
DateNamePosition / FunctionSignature
2020-03-19Ognian DonevExecutive Director
3JR_Annual_Audited_Individual_Financial_Statements_ for_ 2019.zip